PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)
$18.4 0.5 (2.7933%)
Analysed PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) News Sources
PROCEPT BioRobotics Corporation Q2 2026 Earnings Call Summary
05-08-2026
moby.co
PROCEPT BioRobotics (PRCT) Could Be 30% Undervalued Following Class Action Scrutiny
28-07-2026
yahoo.com
The Bull Case For PROCEPT BioRobotics (PRCT) Could Change Following Handpiece Discounting Lawsuits Learn Why
30-07-2026
yahoo.com
PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results
04-08-2026
yahoo.com
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Beats Revenue Estimates
04-08-2026
yahoo.com
PROCEPT BioRobotics Q2 Earnings Call Highlights
05-08-2026
marketbeat.com
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors?
18-08-2026
fool.com
THINK Surgical Appoints Rick McDowell as Vice President, Sales
22-09-2026
yahoo.com
Does New Director and Discounting Lawsuit Change The Bull Case For PROCEPT BioRobotics (PRCT)?
06-10-2026
yahoo.com
PROCEPT BioRobotics (PRCT) Could Be 70% Undervalued On Lawsuit And Board Change
08-10-2026
yahoo.com
What is the current price of PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)?
The current price of PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) is $18.4.
PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) since the previous trading day is $0.5.
PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) since the previous trading day is 2.7933%.
What is the most recent average sentiment score for PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)?
The most recent average sentiment score for PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) is 51 out of 100.
What is the most recent average sentiment for PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)?
The most recent sentiment for PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) is .
SEC-8K** Filing Available For PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.